Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Completed · Phase 2
Conditions studied: Leukemia
In brief
RATIONALE: Monoclonal antibodies, such as gemtuzumab ozogamicin, can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Drugs used in chemotherapy, such as cytarabine, use different ways to stop cancer cells from dividing so they stop growing or die. Combining gemtuzumab ozogamicin with cytarabine may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining gemtuzumab ozogamicin with high-dose cytarabine in treating patients who have relapsed or refractory acute myeloid leukemia.
Key facts
- Study ID
- NCT00006265
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 60
- Starts
- 2001-03-01
- Expected to finish
- 2005-05-01
- Last updated by the study team
- 2016-07-14
Who can join
Age: 17 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Veterans Affairs Medical Center - Birmingham — Birmingham, Alabama, United States
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
- Veterans Affairs Medical Center - San Diego — San Diego, California, United States
- UCSF Comprehensive Cancer Center — San Francisco, California, United States
- Veterans Affairs Medical Center - San Francisco — San Francisco, California, United States
- CCOP - Christiana Care Health Services — Newark, Delaware, United States
- Lombardi Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Washington, DC — Washington D.C., District of Columbia, United States
- Broward General Medical Center — Fort Lauderdale, Florida, United States
- Memorial Regional Hospital Comprehensive Cancer Center — Hollywood, Florida, United States
- CCOP - Mount Sinai Medical Center — Miami Beach, Florida, United States
- Florida Hospital Cancer Institute — Orlando, Florida, United States
- Palm Beach Cancer Institute — West Palm Beach, Florida, United States
- Veterans Affairs Medical Center - Chicago (Westside Hospital) — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Louis A. Weiss Memorial Hospital — Chicago, Illinois, United States
- CCOP - Illinois Oncology Research Association — Peoria, Illinois, United States
- West Suburban Center for Cancer Care — River Forest, Illinois, United States
- Saint Anthony Medical Center — Rockford, Illinois, United States
- Fort Wayne Medical Oncology and Hematology, Incorporated — Fort Wayne, Indiana, United States
- Hematology Oncology Associates of the Quad Cities — Bettendorf, Iowa, United States
- Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
- Baptist Hospital East - Louisville — Louisville, Kentucky, United States
- Northeast Alabama Regional Medical Center — Anniston, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.